To address critical knowledge gaps about the mechanism of action of the CREBRF variant and its biomarker and the potential therapeutic target for diabetes risk we designed the Gestational Diabetes Risk Factors and Outcomes among American Samoan Women (GROW) study. This evidence concerns the gene CREBRF and diabetes mellitus.